@prefix cas: <http://identifiers.org/cas/> .
@prefix chemspider: <http://identifiers.org/chemspider/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix pubchem: <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-Athens_Univ-AU214805 a mbo:MassSpectrum ;
    dcterms:creator "Nikiforos Alygizakis, Reza Aalizadeh, Nikolaos Thomaidis, University of Athens" ;
    dcterms:date "2016-02-22"^^xsd:date ;
    dcterms:identifier "MSBNK-Athens_Univ-AU214805" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights "Copyright (C) 2016 Department of Chemistry, University of Athens under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "Bruker maXis Impact" ;
            mbo:collision_energy "50 eV" ;
            mbo:column_name "Acclaim RSLC C18 2.2um, 2.1x100mm, Thermo" ;
            mbo:flow_gradient "99/1 at 0-1 min, 61/39 at 3 min, 0.1/99.9 at 14-16 min, 99/1 at 16.1-20 min" ;
            mbo:flow_rate "200 uL/min at 0-3 min, 400 uL/min at 14 min, 480 uL/min at 16-19 min, 200 uL/min at 19.1-20 min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "35000" ;
            mbo:retention_time "10.808 min" ;
            mbo:solvent "A 90:10 water:methanol with 0.01% formic acid and 5mM ammonium formate",
                "B methanol with 0.01% formic acid and 5mM ammonium formate" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "Atazanavir",
                "methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate" ;
            mbo:ch_compound_class "N/A; Environmental Standard" ;
            mbo:ch_exact_mass 7.043897e+02 ;
            rdfs:seeAlso cas:198904-31-3,
                chemspider:130642,
                pubchem:CID148192 ;
            schema:inChI "InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1" ;
            schema:inChIKey inchikey:AXRYRYVKAWYZBR-GASGPIRDSA-N ;
            schema:molecularFormula "C38H52N6O7" ;
            schema:name "Atazanavir",
                "methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate" ;
            schema:smiles "CC(C)(C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)[C@H](CN(Cc2ccc(cc2)c3ccccn3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC" ] ;
    mbo:has_peak [ mbo:intensity 2.2212e+04 ;
            mbo:mz 1.200811e+02 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 10 ],
        [ mbo:intensity 1.1572e+04 ;
            mbo:mz 3.632203e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 5 ],
        [ mbo:intensity 2.5736e+04 ;
            mbo:mz 5.343123e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 12 ],
        [ mbo:intensity 2.51768e+05 ;
            mbo:mz 1.441027e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 116 ],
        [ mbo:intensity 1.6452e+04 ;
            mbo:mz 1.451058e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 8 ],
        [ mbo:intensity 1.5056e+04 ;
            mbo:mz 1.460971e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 7 ],
        [ mbo:intensity 9.4492e+04 ;
            mbo:mz 1.670736e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 44 ],
        [ mbo:intensity 2.166916e+06 ;
            mbo:mz 1.680817e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 1.1956e+04 ;
            mbo:mz 3.281833e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 6 ],
        [ mbo:intensity 3.23644e+05 ;
            mbo:mz 3.351994e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 149 ],
        [ mbo:intensity 5.732e+04 ;
            mbo:mz 3.362022e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 26 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 7.054012e+02 ;
            mbo:precursor_mz 7.05397e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 11 ;
    mbo:pk_splash "splash10-014i-0901000000-4a2200f029d64a0c92bc" ;
    rdfs:comment "INTERNAL_ID 2148" ;
    skos:definition "Atazanavir; LC-ESI-QTOF; MS2; CE: 50 eV; R=35000; [M+H]+" .

